JOURNAL OF NEUROTRAUMA
L Iverson G, Preethi R, Posti J, Tenovuo O, Ohman J, Zetterberg H, Blennow K and Luoto T
J. Neurotrauma. Feb 2019.
NNeurofilament light (NF-L) might have diagnostic and prognostic potential as a blood biomarker for mild traumatic brain injury (MTBI). However, elevated NF-L is associated with several neurological disorders associated with older age, which could confound its usefulness as a TBI biomarker. We examined whether NF-L is elevated differentially following uncomplicated MTBI in older adults with pre-injury neurological disorders. In a case-control study, a sample of 118 adults (mean age=62.3 years, SD=22.5, range=18-100; 52.5% women) presenting to the emergency department (ED) with an uncomplicated MTBI were enrolled. All participants underwent head CT in the ED and showed no macroscopic evidence of injury. The mean time between injury and blood sampling was 8.3 hours (Md=3.5; SD=13.5; IQR=1.9-6.0, range=0.8-67.4, and 90% collected within 19 hours). A sample of 40 orthopedically-injured trauma control subjects recruited from a second ED also were examined. Serum NF-L levels were measured and analyzed using Human Neurology 4-Plex A assay on a HD-1 Single molecule array (Simoa) instrument. A high correlation was found between age and NF-L levels in the total MTBI sample (r=.80), within the subgroups without pre-injury neurological diseases (r=.76) and with pre-injury neurological diseases (r=.68), and in the trauma control subjects (r=.76). Those with MTBIs and pre-injury neurological conditions had higher NF-L levels than those with no pre-injury neurological conditions (p<.001, Cohen’s d=1.01). Older age and pre-injury neurological diseases are associated with elevated serum NF-L levels in patients with head trauma and in orthopedically-injured control subjects.
Neurology
Poster Background Developing effective therapies for glioblastoma (GBM) relies on robust preclinical animal models that enable detailed investigation of tumor biology, discovery of therapeutic targets, and evaluation of new treatment…
Oncology
Poster Background Ultrahigh-Plex Single-cell Spatial Phenotyping has revealed valuable insights into the tumor immune microenvironment (TiME) for biomarker discovery and stratification of clinical responses. Metabolic reprogramming is a key hallmark…
Neurology
Alzheimer’s Research and Therapy | August 26, 2024 Sampani K, Ness S, Tuz-Zahra F, Aytan N, Spurlock EE, Alluri S, Chen X, Siegel NH, Alosco ML, Xia W, Tripodis Y,…
Neurology
Poster The intersection of new therapeutic options for Alzheimer’s disease (AD), the emergence of accurate blood-based tests for AD, and the anticipated health system log jam for confirmatory diagnostic testing…
Neurology
Alzheimer’s & Dementia | August 3, 2024 Verberk IMW, Jutte J, Kingma MY, Vigneswaran S, Gouda MMTEE, van Engelen MP, Alcolea D, Arranz J, Fortea J, Lleó A, Chevalier C,…
Neurology
Journal of Lipid Research | August 2, 2024 Becktel DA, Frye JB, Le EH, Whitman SA, Schnellmann RG, Morrison HW, Doyle KP. J Lipid Res. 2024 https://doi.org/10.1016/j.jlr.2024.100614 Abstract Ischemic stroke…
